SG10201605904PA - Predicting progression to advanced age-related macular degeneration using a polygenic score - Google Patents
Predicting progression to advanced age-related macular degeneration using a polygenic scoreInfo
- Publication number
- SG10201605904PA SG10201605904PA SG10201605904PA SG10201605904PA SG10201605904PA SG 10201605904P A SG10201605904P A SG 10201605904PA SG 10201605904P A SG10201605904P A SG 10201605904PA SG 10201605904P A SG10201605904P A SG 10201605904PA SG 10201605904P A SG10201605904P A SG 10201605904PA
- Authority
- SG
- Singapore
- Prior art keywords
- macular degeneration
- related macular
- advanced age
- predicting progression
- polygenic score
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40903910P | 2010-11-01 | 2010-11-01 | |
| US201161573602P | 2011-09-09 | 2011-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201605904PA true SG10201605904PA (en) | 2016-09-29 |
Family
ID=45002128
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201605904PA SG10201605904PA (en) | 2010-11-01 | 2011-11-01 | Predicting progression to advanced age-related macular degeneration using a polygenic score |
| SG2013033337A SG190078A1 (en) | 2010-11-01 | 2011-11-01 | Predicting progression to advanced age-related macular degeneration using a polygenic score |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013033337A SG190078A1 (en) | 2010-11-01 | 2011-11-01 | Predicting progression to advanced age-related macular degeneration using a polygenic score |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US20120107315A1 (en) |
| EP (2) | EP2635704B1 (en) |
| JP (4) | JP2013544512A (en) |
| KR (1) | KR20130130732A (en) |
| CN (1) | CN103201393B (en) |
| AR (1) | AR083677A1 (en) |
| AU (2) | AU2011323487B2 (en) |
| BR (1) | BR112013010769A2 (en) |
| CA (1) | CA2816805A1 (en) |
| DK (1) | DK2635704T3 (en) |
| ES (1) | ES2628806T3 (en) |
| HU (1) | HUE032938T2 (en) |
| IL (1) | IL226063A0 (en) |
| MX (1) | MX348025B (en) |
| NZ (1) | NZ610067A (en) |
| PL (1) | PL2635704T3 (en) |
| RU (2) | RU2016127684A (en) |
| SG (2) | SG10201605904PA (en) |
| SI (1) | SI2635704T1 (en) |
| TW (1) | TW201250003A (en) |
| WO (1) | WO2012061421A1 (en) |
| ZA (1) | ZA201303001B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140067355A1 (en) * | 2012-09-06 | 2014-03-06 | Ancestry.Com Dna, Llc | Using Haplotypes to Infer Ancestral Origins for Recently Admixed Individuals |
| US9737205B2 (en) | 2013-07-31 | 2017-08-22 | The Board Of Trustees Of The Leland Stanford Junior University | Method and system for evaluating progression of age-related macular degeneration |
| US10093978B2 (en) | 2013-08-12 | 2018-10-09 | Genentech, Inc. | Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms |
| US10179821B2 (en) | 2014-05-01 | 2019-01-15 | Genentech, Inc. | Anti-factor D antibodies |
| RU2559090C1 (en) * | 2014-08-27 | 2015-08-10 | Александр Владимирович Кулик | Method for prediction of individual risk of macular dystrophy development |
| TW201730211A (en) | 2015-10-30 | 2017-09-01 | 建南德克公司 | Anti-Factor D antibodies and conjugates |
| JP2018536650A (en) | 2015-10-30 | 2018-12-13 | ジェネンテック， インコーポレイテッド | Anti-factor D antibody variant conjugates and uses thereof |
| JP2019506159A (en) | 2016-01-20 | 2019-03-07 | ヴィトリサ セラピューティクス， インコーポレイテッド | Compositions and methods for inhibiting factor D |
| CN106086222A (en) * | 2016-08-24 | 2016-11-09 | 厦门美因生物科技有限公司 | Motion detecting and evaluating genes method and system based on qPCR typing method |
| JP2020502999A (en) * | 2016-10-30 | 2020-01-30 | タリアツ リミテッドＴａｌｉａｚ Ｌｔｄ． | Methods and systems for predicting a subject's response to antidepressant treatment |
| WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
| WO2018209222A1 (en) * | 2017-05-12 | 2018-11-15 | Massachusetts Institute Of Technology | Systems and methods for crowdsourcing, analyzing, and/or matching personal data |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| CN109585017B (en) * | 2019-01-31 | 2023-12-12 | 上海宝藤生物医药科技股份有限公司 | Risk prediction algorithm model and device for age-related macular degeneration |
| KR20220006010A (en) * | 2020-07-07 | 2022-01-14 | 주식회사 카나프테라퓨틱스 | Fusion protein comprising complement pathway inhibitor and angiogenesis inhibitor and use thereof |
| RU2758662C1 (en) * | 2021-03-19 | 2021-11-01 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Минздрава России) | Method for determining indications for antiangiogenic therapy in case of suspicion of wet form of age-related macular degeneration |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DE3920358A1 (en) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE |
| JPH07501451A (en) | 1991-11-25 | 1995-02-16 | エンゾン・インコーポレイテッド | Multivalent antigen binding protein |
| US6379929B1 (en) * | 1996-11-20 | 2002-04-30 | The Regents Of The University Of Michigan | Chip-based isothermal amplification devices and methods |
| US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7112327B2 (en) | 1998-02-20 | 2006-09-26 | Tanox, Inc. | Inhibition of complement activation |
| US6956107B2 (en) | 1998-02-20 | 2005-10-18 | Tanox, Inc. | Inhibitors of complement activation |
| CA2702192A1 (en) | 2001-03-14 | 2002-09-19 | Genentech, Inc. | Igf antagonist peptides |
| RU2186392C1 (en) * | 2001-04-26 | 2002-07-27 | Должич Галина Ивановна | Method for diagnosing senile macular retinal dystrophy |
| US7758859B2 (en) | 2003-08-01 | 2010-07-20 | Genentech, Inc. | Anti-VEGF antibodies |
| US7127355B2 (en) * | 2004-03-05 | 2006-10-24 | Perlegen Sciences, Inc. | Methods for genetic analysis |
| CN1950826A (en) * | 2004-03-05 | 2007-04-18 | 佩勒根科学有限公司 | Methods for genetic analysis |
| US7527970B2 (en) | 2004-10-15 | 2009-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Method of identifying active chromatin domains |
| JP5068175B2 (en) * | 2005-01-04 | 2012-11-07 | 日立化成工業株式会社 | Primer-generated rolling circle amplification |
| CN103920142A (en) * | 2005-02-14 | 2014-07-16 | 爱荷华大学研究基金会 | Methods And Reagents For Treatment Of Age-related Macular Degeneration |
| CA2725709A1 (en) * | 2005-06-08 | 2006-12-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio N | Susceptibility genes for age-related maculopathy (arm) on chromosome 10q26 |
| CN101355956A (en) | 2005-11-04 | 2009-01-28 | 健泰科生物技术公司 | Use of complement pathway inhibitors to treat ocular diseases |
| US20080146501A1 (en) * | 2006-02-13 | 2008-06-19 | University Of Iowa Research Foundation | Protective complement proteins and age-related macular degeneration |
| JP2010526555A (en) * | 2007-05-11 | 2010-08-05 | タフツ・メディカル・センター | Polynucleotides associated with age-related macular degeneration and methods for assessing patient risk |
| AR066660A1 (en) * | 2007-05-23 | 2009-09-02 | Genentech Inc | PREVENTION AND TREATMENT OF EYE CONDITIONS ASSOCIATED WITH THEIR COMPLEMENT |
| US20090203001A1 (en) * | 2007-08-24 | 2009-08-13 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating macular degeneration |
| EP2283163B1 (en) * | 2008-04-18 | 2015-07-08 | Tufts Medical Center | Polymorphisms associated with age-related macular degeneration and methods for evaluating patient risk |
| AT506998B1 (en) * | 2008-06-30 | 2010-03-15 | Fronius Int Gmbh | CONTACT TUBE FOR A WELDING BURNER |
| US20120115925A1 (en) * | 2008-12-23 | 2012-05-10 | Massachusetts Eye And Ear Infirmary | Allelic Variants Associated with Advanced Age-Related Macular Degeneration |
| WO2010085542A2 (en) * | 2009-01-23 | 2010-07-29 | Novartis Ag | Biomarkers related to age-related macular degeneration (amd) |
-
2011
- 2011-11-01 ES ES11785527.0T patent/ES2628806T3/en active Active
- 2011-11-01 EP EP11785527.0A patent/EP2635704B1/en active Active
- 2011-11-01 BR BR112013010769A patent/BR112013010769A2/en not_active IP Right Cessation
- 2011-11-01 SG SG10201605904PA patent/SG10201605904PA/en unknown
- 2011-11-01 CN CN201180052312.1A patent/CN103201393B/en not_active Expired - Fee Related
- 2011-11-01 NZ NZ610067A patent/NZ610067A/en not_active IP Right Cessation
- 2011-11-01 AR ARP110104052A patent/AR083677A1/en unknown
- 2011-11-01 WO PCT/US2011/058829 patent/WO2012061421A1/en active Application Filing
- 2011-11-01 CA CA2816805A patent/CA2816805A1/en not_active Abandoned
- 2011-11-01 JP JP2013536932A patent/JP2013544512A/en not_active Withdrawn
- 2011-11-01 RU RU2016127684A patent/RU2016127684A/en unknown
- 2011-11-01 HU HUE11785527A patent/HUE032938T2/en unknown
- 2011-11-01 SG SG2013033337A patent/SG190078A1/en unknown
- 2011-11-01 MX MX2013004879A patent/MX348025B/en active IP Right Grant
- 2011-11-01 US US13/317,949 patent/US20120107315A1/en not_active Abandoned
- 2011-11-01 AU AU2011323487A patent/AU2011323487B2/en not_active Ceased
- 2011-11-01 RU RU2013125230/10A patent/RU2593954C2/en not_active IP Right Cessation
- 2011-11-01 TW TW100139739A patent/TW201250003A/en unknown
- 2011-11-01 SI SI201131208A patent/SI2635704T1/en unknown
- 2011-11-01 DK DK11785527.0T patent/DK2635704T3/en active
- 2011-11-01 PL PL11785527T patent/PL2635704T3/en unknown
- 2011-11-01 KR KR1020137014161A patent/KR20130130732A/en not_active Application Discontinuation
- 2011-11-01 EP EP16193134.0A patent/EP3170905A1/en not_active Withdrawn
-
2013
- 2013-04-24 ZA ZA2013/03001A patent/ZA201303001B/en unknown
- 2013-04-30 IL IL226063A patent/IL226063A0/en unknown
-
2014
- 2014-03-04 US US13/999,496 patent/US20140286947A1/en not_active Abandoned
-
2016
- 2016-02-16 JP JP2016027382A patent/JP2016154538A/en active Pending
- 2016-11-08 AU AU2016256692A patent/AU2016256692A1/en not_active Abandoned
-
2017
- 2017-07-18 US US15/653,460 patent/US20180163262A1/en not_active Abandoned
- 2017-10-19 JP JP2017202311A patent/JP2018068285A/en not_active Withdrawn
-
2019
- 2019-08-02 JP JP2019143107A patent/JP2019216732A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL226063A0 (en) | Predicting progression to advanced age-related macular degeneration using a polygenic score | |
| EP2751651A4 (en) | Arranging tiles | |
| GB201118636D0 (en) | Nucleotide sequence | |
| EP2696949A4 (en) | A binding | |
| GB201203122D0 (en) | A stimulator | |
| EP2788516A4 (en) | Starting a smelting process | |
| PL2788515T3 (en) | Starting a smelting process | |
| EP2692257A4 (en) | Brazier | |
| ZA201306185B (en) | Germanosilicate ssz-75 | |
| EP2788514A4 (en) | Starting a smelting process | |
| HK1150490A2 (en) | A clamping-switch bracelet | |
| ZA201405359B (en) | Predicting progression to advanced age-related macular degeneration using a polygenic score | |
| GB2481327B (en) | A toy | |
| GB201200412D0 (en) | A rake | |
| GB201115357D0 (en) | Carrom pieces setting aid | |
| GB201220680D0 (en) | Antibacterials | |
| AU338564S (en) | A timer | |
| AU339844S (en) | A link | |
| GB201121369D0 (en) | A chain | |
| GB201112900D0 (en) | A flue | |
| GB201121138D0 (en) | Placement game | |
| AU336621S (en) | Chocolate dipper | |
| AU340785S (en) | Toaster | |
| AU340786S (en) | Toaster | |
| GB201113486D0 (en) | Project grow |